Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 159

1.

Presence of gastro-intestinal symptoms in ovarian cancer patients during survivorship: a cross-sectional study from the PROFILES registry.

Rietveld MJA, Husson O, Vos MCC, van de Poll-Franse LV, Ottevanger PBN, Ezendam NPM.

Support Care Cancer. 2018 Oct 17. doi: 10.1007/s00520-018-4510-9. [Epub ahead of print]

PMID:
30328539
2.

Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study.

Islam B, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, van Doorn PA, Jacobs BC, Mohammad QD.

BMJ Open. 2018 Aug 17;8(8):e022862. doi: 10.1136/bmjopen-2018-022862.

3.

Corrigendum to 'Antiseptic barrier cap effective in reducing central line-associated bloodstream infections: A systematic review and meta-analysis' [Int J Nurs Stud. 69. (2017) 34-40].

Voor In 't Holt AF, Helder OK, Vos MC, Schafthuizen L, Sülz S, Hoogen AVD, Ista E.

Int J Nurs Stud. 2018 Aug;84:79-80. doi: 10.1016/j.ijnurstu.2017.08.001. No abstract available.

PMID:
29887034
4.

Association between information provision and supportive care needs among ovarian cancer survivors: A cross-sectional study from the PROFILES registry.

Rietveld MJA, Husson O, Vos MCC, van de Poll-Franse LV, Ottevanger PBN, Ezendam NPM.

Psychooncology. 2018 Aug;27(8):1922-1929. doi: 10.1002/pon.4742. Epub 2018 May 16.

PMID:
29683231
5.

ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial.

Ezendam NPM, de Rooij BH, Kruitwagen RFPM, Creutzberg CL, van Loon I, Boll D, Vos MC, van de Poll-Franse LV.

Trials. 2018 Apr 16;19(1):227. doi: 10.1186/s13063-018-2611-x.

6.

An experimental Staphylococcus aureus carriage and decolonization model in rhesus macaques (Macaca mulatta).

Slingerland BCGC, Keehnen M, Ouwerling B, Tavakol M, Snijders SV, Verbrugh HA, Vos MC, Remarque EJ, Langermans JAM, van Wamel WJB.

PLoS One. 2018 Apr 12;13(4):e0194718. doi: 10.1371/journal.pone.0194718. eCollection 2018.

7.

High prevalence rate of digestive tract bacteria in duodenoscopes: a nationwide study.

Rauwers AW, Voor In 't Holt AF, Buijs JG, de Groot W, Hansen BE, Bruno MJ, Vos MC.

Gut. 2018 Sep;67(9):1637-1645. doi: 10.1136/gutjnl-2017-315082. Epub 2018 Apr 10.

8.

Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study.

Bonhof CS, Mols F, Vos MC, Pijnenborg JMA, Boll D, Vreugdenhil G, Ezendam NPM, van de Poll-Franse LV.

Gynecol Oncol. 2018 Jun;149(3):455-463. doi: 10.1016/j.ygyno.2018.03.052. Epub 2018 Mar 28.

PMID:
29605500
9.

Corrigendum to 'Panton-Valentine Leucocidin (PVL) Staphylococcus aureus a position statement from the International Society of Chemotherapy' [International Journal of Antimicrobial Agents 51/1 (2018) 16-25].

Saeed K, Gould I, Esposito S, Ahmad-Saeed N, Ahmed SS, Alp E, Bal AM, Bassetti M, Bonnet E, Chan M, Coombs G, Dancer SJ, David MZ, De Simone G, Dryden M, Guardabassi L, Hanitsch LG, Hijazi K, Kruger R, Lee A, Leistner R, Pagliano P, Righi E, Schneider-Burrus S, Skov RL, Tattevin P, VanWamel W, Vos MC, Voss A; International Society of Chemotherapy.

Int J Antimicrob Agents. 2018 Jul;52(1):125. doi: 10.1016/j.ijantimicag.2018.03.005. Epub 2018 Mar 21. No abstract available.

PMID:
29571899
10.

Survivorship care plans have a negative impact on long-term quality of life and anxiety through more threatening illness perceptions in gynecological cancer patients: the ROGY care trial.

de Rooij BH, Ezendam NPM, Nicolaije KAH, Lodder P, Vos MC, Pijnenborg JMA, Boll D, Kruitwagen RFPM, van de Poll-Franse LV.

Qual Life Res. 2018 Jun;27(6):1533-1544. doi: 10.1007/s11136-018-1825-4. Epub 2018 Mar 6.

11.

VIM-positive Pseudomonas aeruginosa in a large tertiary care hospital: matched case-control studies and a network analysis.

Voor In 't Holt AF, Severin JA, Hagenaars MBH, de Goeij I, Gommers D, Vos MC.

Antimicrob Resist Infect Control. 2018 Feb 27;7:32. doi: 10.1186/s13756-018-0325-1. eCollection 2018.

12.

Recurrent Cancer Is Associated With Dissatisfaction With Care-A Longitudinal Analysis Among Ovarian and Endometrial Cancer Patients.

de Rooij BH, Ikiz H, Boll D, Pijnenborg JMA, Pijlman BM, Kruitwagen RFPM, van de Poll-Franse LV, Vos MC, Ezendam NPM.

Int J Gynecol Cancer. 2018 Mar;28(3):614-622. doi: 10.1097/IGC.0000000000001204.

PMID:
29466257
13.

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.

Harmsen MG, Steenbeek MP, Hoogerbrugge N, van Doorn HC, Gaarenstroom KN, Vos MC, Massuger LFAG, de Hullu JA, Hermens RPMG.

Health Expect. 2018 Jun;21(3):659-667. doi: 10.1111/hex.12661. Epub 2017 Dec 27.

14.

Newly identified risk factors for MRSA carriage in The Netherlands.

Lekkerkerk WSN, Haenen A, van der Sande MAB, Leenstra T, de Greeff S, Timen A, Tjon-A-Tsien A, Richardus JH, van de Sande-Bruinsma N, Vos MC.

PLoS One. 2017 Nov 30;12(11):e0188502. doi: 10.1371/journal.pone.0188502. eCollection 2017.

15.

Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy.

Saeed K, Gould I, Esposito S, Ahmad-Saeed N, Ahmed SS, Alp E, Bal AM, Bassetti M, Bonnet E, Chan M, Coombs G, Dancer SJ, David MZ, De Simone G, Dryden M, Guardabassi L, Hanitsch LG, Hijazi K, Krüger R, Lee A, Leistner R, Pagliano P, Righi E, Schneider-Burrus S, Skov RL, Tattevin P, Van Wamel W, Vos MC, Voss A; International Society of Chemotherapy.

Int J Antimicrob Agents. 2018 Jan;51(1):16-25. doi: 10.1016/j.ijantimicag.2017.11.002. Epub 2017 Nov 22. No abstract available. Erratum in: Int J Antimicrob Agents. 2018 Mar 20;:.

PMID:
29174420
16.

Opportunistic salpingectomy in women undergoing hysterectomy: Results from the HYSTUB randomised controlled trial.

Van Lieshout LAM, Pijlman B, Vos MC, de Groot MJM, Houterman S, Coppus SFPJ, Harmsen MG, Vandenput I, Piek JMJ.

Maturitas. 2018 Jan;107:1-6. doi: 10.1016/j.maturitas.2017.09.012. Epub 2017 Oct 3.

PMID:
29169572
17.

A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

van Loon K, Voor In 't Holt AF, Vos MC.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01730-17. doi: 10.1128/AAC.01730-17. Print 2018 Jan.

18.

Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study.

Islam MB, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, van Doorn PA, Jacobs BC, Mohammad QD.

Pilot Feasibility Stud. 2017 Sep 29;3:40. doi: 10.1186/s40814-017-0185-0. eCollection 2017.

19.

Contribution of Prior, Multiple-, and Repetitive Surgeries to the Risk of Surgical Site Infections in the Netherlands.

Verberk JDM, Meijs AP, Vos MC, Schreurs LMA, Geerlings SE, de Greeff SC, Koek MBG.

Infect Control Hosp Epidemiol. 2017 Nov;38(11):1298-1305. doi: 10.1017/ice.2017.195. Epub 2017 Sep 18.

PMID:
28918773
20.

Adhering to a national surgical care bundle reduces the risk of surgical site infections.

Koek MBG, Hopmans TEM, Soetens LC, Wille JC, Geerlings SE, Vos MC, van Benthem BHB, de Greeff SC.

PLoS One. 2017 Sep 6;12(9):e0184200. doi: 10.1371/journal.pone.0184200. eCollection 2017.

Supplemental Content

Loading ...
Support Center